SlideShare a Scribd company logo
1 of 85
syndrome gastric dyspepsia.
Dyspepsia - digestive disorders of different origin
s. There are gastric and intestinal dyspepsia. T
he term "gastric dyspepsia" combines symptom
s such as heartburn, belching, regurgitation, na
usea, vomiting, hiccups. They are observed not
only in various diseases of the stomach, but in
diseases of other organs and systems (central
nervous system, endocrine system, liver, biliary
tract, kidneys, and others.).
The organic reasons of dyspepsia:
• Gastritis;
• Stomach ulcer;
• Reflux- esophagitis;
• Stomach cancer;
• Cholelithiasis;
• Chronic pancreatitis.
Gastritis - inflammation of the mucous
membrane of the stomach wall.
common causes of gastritis.
The most common cause of gastritis is the
bacterium Helicobacter pylori, however, co
ntribute to the development of gastritis ma
y be poor nutrition, constant stress, smoki
ng, alcoholism, medications, error in nutriti
on.
types of gastritis.
etiological
• 1. Helicobacter pylori (associated with Helicoba
cter pylori)
• 2. Autoimmune
• 3. Reactive (due to duodenal reflux, bile reflux i
nto the stomach or taking drugs)
• 4. Special forms of gastritis (granulomatous, inc
luding Crohn's disease, sarcoidosis, tuberculosi
s, lymphocytic, eosinophilic)
types of gastritis.
on the course of the disease.
• acute gastritis
• chronic gastritis
topography
• 1. Gastritis antrum
• 2. The body of the stomach Gastritis
• 3. pangastritis
types of gastritis.
Endoscopic gastritis categories:
• 1. erythematous-exudative (surface), gastritis
• 2. atrophic gastritis
• 3. hemorrhagic gastritis
• 4. hyperplastic gastritis
Chronic H. pylori gastritis
In the early stages of the disease developing atr
ophic antral gastritis without secretory failure.
Ulcer-like symptoms:
• Pain in the epigastric 1-2 hours after a meal
• Hunger pain (fasting)
• Heartburn, acid regurgitation
• A healthy appetite
• The tendency to constipation
Objective clinical symptoms:
• Language clean or slightly coated from root
• Local tenderness in the area piloroduodenalnoy
• Normal border stomach
In the late stages of the disease devel
ops diffuse gastritis with atrophy of th
e gastric mucosa and the secretory de
ficiency.
Clinical symptoms:
• Poor appetite, nausea
• metallic taste in the mouth, dry mouth
• Belching air, food, sometimes rotten
• The feeling of heaviness in the epigastric
• Dull epigastric pain after eating
• Rumbling and flatulence
• Frequent loose stools
Objective symptoms
• Weight loss
• Language thickly coated
• Perleches in the corners of the mouth
• Moderate diffuse pain in the epigastric region
• Omission of the lower boundary of the stomach
• Rumbling palpation of the large intestine due to t
he pronounced flatulence
Perleches in the corners of the mouth
survey
X - ray examination of the stomach:
• Early stage (non-atrophic gastritis) - rough terrai
n mucosa in the antrum, pyloric spasm, segmen
ted peristalsis, disorderly evacuation of a contra
st agent.
• Late stage (pangastritis with atrophy) - relief of g
astric mucosa smoothed, hypotension, sluggish
perstaltika, fast evacuation of contrast material.
X - ray examination of the stomach
Gastroscopy
• Early stage (non-atrophic gastritis) - blotchy red
ness and swelling of the mucous membrane of t
he antrum, frequent submucosal hemorrhage, e
rosion, hyperplasia folds, exudation, antral spas
ms, stasis.
• Late stage (pangastritis with atrophy) - paleness
, thinning, flattening of the mucous membrane i
n the stomach and the antrum, blotchy flushing,
candling vascular hypotension, increased vulne
rability of the mucous, reflux of duodenal conten
ts.
Gastroscopy
Gastroscopy
Mucosal erythema and edema co
nsistent with acute gastritis.
Acute gastritis with superficial ero
sions.
Histopathological examination (biopsy taken at least
2 pieces of the antrum and the body (front and rear), a
lways with a muscular plate):
• Early stage (non-atrophic gastritis) - pronounced active
antral gastritis (infiltration own skin epithelial lymphocy
tes, plasmocytes, neutrophils), foci of intestinal metapl
asia, a lot of helicobacter surface and mucous pits.
• Late stage (pangastritis with atrophy) - glandular epithe
lium atrophy, intestinal metaplasia, a small amount of
helicobacter in gastric mucosa and antrum, the minim
al activity of inflammation.
Diagnosis of Helicobacter pylory:
Histological method for determining Helicobacter
pylori is the gold standard of diagnosis:
• Thin slices of biopsy specimens stained by the
method of Giemsa-Romanovsky, Helicobacter l
ocated in the mucus, have a spiral shape.
There are three degrees of contamination Helioba
cter pylory:
• Low () - 20 microbial cells in the s.v.
• Average (++) - up to 50 microbial cells in the s.v
.
• High (+++) - more than 50 microbial cells in the
s.v.
Chronic autoimmune gastritis.
Chronic autoimmune gastritis is chara
cterized by lesions of the gastric fund
us, atrophy of the gastric mucosa and
the secretory deficiency.
Subjective symptoms
• feeling of heaviness and fullness after eating
• Belching air, rotten, food sedennoy
• metallic taste in the mouth
• Poor appetite
• Rumbling transfusions and stomach, unstable st
ool
• severe weakness, dizziness, sweating (function
al dumping syndrome)
Objective symptoms
• Weight Loss
• pale skin (anemia), hair loss, brittle nails
• Dry skin, hyperpigmentation (gipokortitsizm)
• Signs gipopolivitaminoza (dry skin, blurred vision, blee
ding of gums and loosening, Zayed corners of mouth,
dermatitis, diarrhea)
• coated tongue
• Sore epigastrii
• Morbidity and rumbling in the umbilical and the ileocec
al region
• Omission of the greater curvature of the stomach
X-ray examination of the stomach
Improvement in the folds of the stomach lining
Gastroscopy
• The folds of the gastric mucosa are reduced in v
olume, in advanced cases of atrophy, they can
be absent
• stomach lining thinned, atrophic, pale, clearly vi
sible vascular pattern, an excessive amount of
mucus
• hiatus gatekeeper, throw the stomach contents
of 12 duodenal ulcer, gastric motility sluggish
• antrum is not changed
Histopathological examination
• atrophy of the mucous membrane of the fundus
of the stomach with the replacement of speciali
zed glands psevdopiloric glands and intestinal e
pithelium.
Immunological blood tests
• The presence of autoantibodies to parietal cells
and gastromukoproteinu.
Special forms of gastritis.
Hypertrophic gastritis (Menetries disease).
Subjective symptoms:
• Intense epigastric pain occurring after meals, he
artburn, regurgitation, air and food
• Frequent vomiting with blood
• Anorexia
• Weight loss, swelling of the feet and hands
• Diarrhea
• Hypoproteinemia
Special forms of gastritis.
Hypertrophic gastritis (Menetries disease).
Gastroscopy:
• Hypertrophy of the mucous membrane in the for
m of giant folds, covered with lots of sticky muc
us.
Histopathological examination:
• The sharp thickening of the gastric mucosa, ext
ension and expansion of the gastric pits
Hypertrophic gastritis (illness Menet
ries).
treatment
treatment
1. Sparing diet. Vegetables boiled, steamed zucc
hini, potatoes, carrots, cabbage, beans, beets,
dairy products, fruit and berry juices, sauces,
spices, snacks, tea, coffee and black with milk
, broth hips, black currant). Excluded are indig
estible, long linger in the stomach and dishes.
Fractional meals 4-5 times a day.
treatment
Anti-inflammatory therapy
• Sucralfate (Venter) Tablets (1 g) 1 tab four time
s daily (for 1 hour before meals and at bedtime)
or 2 g in the morning and evening. The course
of treatment 2-4 weeks
or
• De-nol (colloidal bismuth subcitrate) Tablets (12
0 mg) 1 tablet three times a day 30 minutes bef
ore meals and at bedtime. The course of treatm
ent 4 - 8 weeks. For 30 minutes before and afte
r taking the drug should not take antacids, milk,
beverages, solid food.
treatment
Cementing and enveloping substance
• Allonton (drug inula) Tablets (0.1) 1 tab. 2-4 tim
es for 30 min. before meals
or
• Kaleflon (extract from marigold flowers) Tablets
(0.1) Table 1-2. 3 times per day after meals
treatment
Stimulators of gastric secretion
• Trental (metabolic drug in combination with the i
mprovement of microcirculation) 100 mg 1-2 tab
. 3 times for 30 min. before meals for 1-2 month
s.
or
• Pentagastrin (synthetic analog of histamine) Am
poule 0.025% -1.0 s/c before meal 1-2 times a
day for two weeks
treatment
replacement therapy drugs.
• Gastric juice natural vials of 1-2 tablespoons int
o ½ cup of water through a straw while eating
or
• Citric acid powder on the tip of a knife into ¼ cu
p of water with meals
or
• Atsidin-pepsin tablets (0.5) Table 1. dissolved in
½ cup of water with meals
treatment
prokinetics.
• Metoclopramide (raglan, Reglan) Tablets (0.01)
Ampules (1 ml-0.005) 10-20 mg 3-4 times a day
for 15-30 minutes before meal, maximum daily
dose of 60 mg
or
• Motilium (domperidone) Tablets 0.01 mg 10-20
3-4 times a day for 15-30 minutes before meals,
daily dose - 60 mg
treatment
• Pancreatin Tablets 0.5-1.0 The enzyme prepara
tion from the pancreas of beef cattle. Table 1-2.
before meals 3-4 times
or
• Mezim forte preparation containing pancreatic e
nzymes 1-2 tab. 3 times daily before or during
meals
treatment
Antibiotics to treat Helicobacter pylori
Peptic ulcer
Peptic ulcer - an independent (primary) chronic
relapsing disease gastroduodenal region with th
e formation of ulcers of the stomach and duode
num.
Peptic ulcer
Peptic ulcer duodenal bulb (PUD) occurs 4 time
s more often than gastric ulcer (GU).
Peptic ulcer duodenal bulb - is more common in t
he age range 25-75 years (rarely less than 15 y
ears).
GU - occurs more often aged 55-65 (rarely young
er than 40 years).
The criteria for early diagnosis.
• epigastric pain - in the center or left of the midlin
e at a stomach ulcer, epigastric right of the midli
ne - duodenal ulcer and prepiloric area with ga
stric cardia of the stomach - in the sternum.
• Early pain (30 minutes - 1 hour after a meal) - at
the top of the stomach ulcer, recent pain (1.5 -
2 hours after a meal), night and hungry (after 6-
7 hours after eating) - ulcer antral department a
nd duodenal ulcer.
The criteria for early diagnosis.
• Dumb nature of pain can be aching, boring
• The frequency of pain
• Relief of pain - after antacids, milk, food, of
ten after vomiting
• Seasonality pain - spring, autumn, charact
erized more for duodenal ulcer
• Heartburn
The criteria for early diagnosis.
• Belching, often occurs in the localization fi
eld mesogastric
• Nausea – characteristic for mediogastral ul
cers, but not characteristic of ulcer 12 duo
denal ulcer
• Vomiting - at an altitude of pain
• Appetite - kept, good
The criteria for early diagnosis.
objective:
• Asthenia
• The tendency to bradycardia
• Tendency to hypertension
• Moderate or severe pain in the epigastric in acut
e: gastric ulcer - midline or left, ulcer 12 duoden
al ulcer over the right
• percussion tenderness over the area of the ulcer
- a symptom of Mendel
• Local protective tension anterior abdominal wall
The criteria for early diagnosis.
Laboratory research:
• CBC - a slight increase in red blood cells and h
emoglobin
• Fecal occult blood test (reaction Gregersen) - p
ositive for bleeding from the ulcer
The criteria for early diagnosis.
Endoscopy:
• Ulcers round, polygonal or slit form
• Borders ulcers crisp, edge bloodshot, swollen
• Undermining the ulcer edge (facing the cardiac
department), the distal end flat
• The bottom of the ulcer is covered with fibrin
Gastroscopy procedure
Gastric ulcer with punched-out ulcer
base with whitish fibrinoid exudates.
Gastric ulcer (lesser curvature) with punched
-out ulcer base with whitish exudate.
The criteria for early diagnosis.
X-rays:
Direct indication of the "niche"
Indirect signs:
• Delay barium mass at the site of the ulcer (contrast stai
n resistant)
• Delayed or accelerated passage of barium sulfate of st
omach
• Duodenalnogastralny reflux
• Convergence folds at locations ulcers
• Lack of cardia, gastroesophageal reflux
• Local stomach cramps or 12 duodenal ulcer
• Symptom De Quervain - circular retraction of the muscl
es on the opposite side of the stomach ulcer - deforma
tion of the stomach and duodenum
X-rays
Determination Helicobacter pylori
• urease breath test - identifying exhaled C13 isotopes w
hich are formed in the stomach during digestion drunk
labeled urea by the action of urease HP
• histological methods - detection of HP in biopsies stain
ed by the method of Giemsa
• urease biopsy test - determination of urease activity of
HP in biopsies
• The bacteriological test - the growth of HP biopsy
• Immunological methods - determination of antibodies in
the blood to HP, HP detection of antigen in stool
Required laboratory tests
• Complete blood count - once (In the event of rep
eated study of 1 every 10 days)
• Blood type
• Fecal occult blood test
The severity of the ulcer
Mild - is characterized by the following features:
• Exacerbations 1 time in 1-3 years
• Pain syndrome moderate pain stoped for 4-7 da
ys
• shallow ulcer
• The remission disabled preserved
The severity of the ulcer
moderate severity:
• Relapse 2 times a year
• Pain syndrome pronounced pain stoped in the h
ospital for 10-14 days
• Characterized dyspepsia
• Ulcers deep, often bleeds, accompanied by phe
nomena perigastritis, periduodenitis
The severity of the ulcer
Severe:
• Relapse 2-3 times a year and more
• Pain and pronounced cropped in the hospital for
2 weeks or more
• Sharply expressed dyspeptic symptoms and wei
ght loss
• The ulcer is often complicated by bleeding, deve
lopment of pyloric stenosis, perigastritis, peridu
odenitis
Complications of peptic ulcer disease.
• Peptic ulcer bleeding is observed in 15-25% of patie
nts with peptic ulcer disease, often with stomach ulcer
s localization
• Ulcer perforation occurs in 5% of patients with peptic
ulcer disease, more common in men.
• Penetration - penetration of gastric ulcer or duodenal
ulcer in the surrounding tissues: the pancreas, a small
gland, gall bladder, and others.
• Perivistserit - adhesive process that evolves with ulce
rs between the stomach or duodenum and adjacent or
gans (pancreas, liver, gall bladder). duodenum.
Ulcer emergencies
Complications of peptic ulcer disease.
• Pyloric stenosis usually formulated after ulc
er healing located in the pyloric channel or the i
nitial part of the duodenum, is found in 5% of pa
tients.
• The risk of malignancy (adenocarcinoma devel
opment) benign ulcers when infected with HP 9
times more likely than uninfected patients.
treatment
1. Medical treatment - mental and physical rest, n
ot strict bed rest for 7-10 days, then free.
2. Diet - table 1 a, 1 b for 2-3 days, then the table
1. The food is cooked, but not shabby, eat 5-6 ti
mes a day are not recommended sharp, pickled
, smoked food. The optimum amount of protein i
n the diet of 120-125 g / day.
3. Giving up smoking.
4. Pharmacotherapy.
treatment
H. pylori therapy
• First-line therapy (triple therapy) for 7 days
Omeprazole 20 mg 2 times a day, or
Lansoprazole 30 mg 2 times a day, or
Pantoprozol 40 mg 2 times a day
+
Clarithromycin 500 mg 2 times a day
+
Amoxicillin 1000 mg 2 times a day
or
Clarithromycin 500 mg 2 times a day
+
Metronidazole 500 mg 2 times a day
treatment
H. pylori therapy
• First-line therapy (triple therapy) for 7 days
Omeprazole 20 mg 2 times a day,
Clarithromycin 500 mg 2 times a day
Amoxicillin 1000 mg 2 times a day
treatment
H. pylori therapy
Second-line therapy (quadruple) for 7 days
Omeprazole 20 mg 2 times a day, or
Lansoprazole 30 mg 2 times a day, or
Pantoprozol 40 mg 2 times a day
+
Bismuth subsalicylate 120 mg four times a day
+
Metronidazole 500 mg three times a day
+
Tetracycline 500 mg four times a day
treatment
H. pylori therapy
Second-line therapy (quadruple) for 7 days
Omeprazole 20 mg 2 times a day,
Bismuth subsalicylate 120 mg four times a day
Metronidazole 500 mg three times a day
Tetracycline 500 mg four times a day
stomach cancer
stomach cancer
Stomach cancer - a malignant tumor growing fro
m the epithelial cells of the mucosa (inner) mem
brane of the stomach. Swelling can occur in diff
erent parts of the stomach: at the top, where it c
onnects with the esophagus, in the main part (b
ody) of the stomach or in the bottom where the
stomach is connected to the intestines.
stomach cancer
Risk factors for gastric cancer
• Genetic predisposition - if someone in the family d
iagnosed with stomach cancer, then all the other r
elatives (blood) relatives likely to develop increase
d by 20%;
• eating habits - overreliance smoked, spicy, salty, f
ried (overcooked) and canned food, long stored fo
ods containing nitrates, significantly increases the
risk of stomach cancer;
• long-existing diseases of the stomach: gastritis (w
ith low acidity), ulcers and polyps of the stomach;
• gastric surgery increases the risk of gastric cance
r development is 2.5 times;
stomach cancer
Risk factors for gastric cancer
• the presence of the stomach bacterium Helicobact
er pylori: In 1994 the World Health Organization (W
HO) has recognized the link between Helicobacter
Pylori and stomach cancer and the bacteria broug
ht it into the category of carcinogens of the first cl
ass;
• Work with asbestos and nickel;
• deficiency of vitamin B12, and C;
• primary and secondary (e.g., AIDS), immunodefici
ency states;
• 20 times more common in gastric cancer patients
with pernicious (malignant) anemia;
• Some viruses, such as Epstein-Barr virus;
• alcoholism and smoking.
stomach cancer
clinical picture
• decreased appetite;
• changes in eating habits, for example, they feel
an aversion to meat, fish and etc .;
• rise in temperature (usually 37-38 ° C);
• anemia (decreased hemoglobin).
stomach cancer
clinical picture
With the growth of stomach cancer, new symptoms:
• a feeling of heaviness in the stomach after eating, nau
sea and vomiting, fast saturation;
• violation stool (diarrhea, constipation);
• pain in the upper abdomen, girdle pain, smack in the b
ack (in the propagation of the tumor in the pancreas);
• increasing the size of the stomach, fluid accumulation i
n the abdomen (ascites);
• weight loss;
• the destruction of tumor blood vessels may develop ga
strointestinal bleeding.
Physical examination
Objective methods of inspection (survey, pa
lpation, percussion) allow revealing a stom
ach cancer only at late stages of disease.
TOOL METHODS of INVESTIGATION
• gastroscopy with biopsies.
• computed tomography
• US
• x-ray study.
Gastric cancer. Note the irregul
ar heaped up overhanging margi
ns.
Gastric cancer with ulcerated ma
ss.
Thank you for the attention.

More Related Content

What's hot

Clinical approach to a patient complaining of polyuria
Clinical approach to a patient complaining of polyuriaClinical approach to a patient complaining of polyuria
Clinical approach to a patient complaining of polyuriaAbino David
 
Management of Gastrointestinal Lymphomas
Management of Gastrointestinal LymphomasManagement of Gastrointestinal Lymphomas
Management of Gastrointestinal LymphomasSantam Chakraborty
 
Gastro-oesophageal Reflux Disease by Anish Dhakal (Aryan)
Gastro-oesophageal Reflux Disease by Anish Dhakal (Aryan)Gastro-oesophageal Reflux Disease by Anish Dhakal (Aryan)
Gastro-oesophageal Reflux Disease by Anish Dhakal (Aryan)Dr. Aryan (Anish Dhakal)
 
Systemic sclerosis
Systemic sclerosisSystemic sclerosis
Systemic sclerosisfarranajwa
 
Presentation on small intestine disorder
Presentation on small intestine disorder Presentation on small intestine disorder
Presentation on small intestine disorder RakhiYadav53
 
Management of Inflammatory Bowel Disease
Management of Inflammatory Bowel DiseaseManagement of Inflammatory Bowel Disease
Management of Inflammatory Bowel Diseasedrnkhokhar
 
Pathophysiology of obstructive jaundice
Pathophysiology of obstructive jaundicePathophysiology of obstructive jaundice
Pathophysiology of obstructive jaundiceVignesh Kumar
 
an Approach to Dyspepsia
an Approach to Dyspepsiaan Approach to Dyspepsia
an Approach to DyspepsiaAhmed Almumtin
 
Inflammatory bowel disease
Inflammatory bowel  diseaseInflammatory bowel  disease
Inflammatory bowel diseaseDrNikithaValluri
 
GERD / GASTRO ESOPHAGEAL REFLUX
GERD / GASTRO ESOPHAGEAL REFLUX GERD / GASTRO ESOPHAGEAL REFLUX
GERD / GASTRO ESOPHAGEAL REFLUX Arun Karmakar
 
inflammatory bowel disease
inflammatory bowel diseaseinflammatory bowel disease
inflammatory bowel diseaserahul arora
 
Liver & its diseases
Liver & its diseasesLiver & its diseases
Liver & its diseasesRAJESH EAPEN
 

What's hot (20)

Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
GERD
GERDGERD
GERD
 
Clinical approach to a patient complaining of polyuria
Clinical approach to a patient complaining of polyuriaClinical approach to a patient complaining of polyuria
Clinical approach to a patient complaining of polyuria
 
Management of Gastrointestinal Lymphomas
Management of Gastrointestinal LymphomasManagement of Gastrointestinal Lymphomas
Management of Gastrointestinal Lymphomas
 
Gastro-oesophageal Reflux Disease by Anish Dhakal (Aryan)
Gastro-oesophageal Reflux Disease by Anish Dhakal (Aryan)Gastro-oesophageal Reflux Disease by Anish Dhakal (Aryan)
Gastro-oesophageal Reflux Disease by Anish Dhakal (Aryan)
 
Systemic sclerosis
Systemic sclerosisSystemic sclerosis
Systemic sclerosis
 
Presentation on small intestine disorder
Presentation on small intestine disorder Presentation on small intestine disorder
Presentation on small intestine disorder
 
Vomiting
VomitingVomiting
Vomiting
 
Management of Inflammatory Bowel Disease
Management of Inflammatory Bowel DiseaseManagement of Inflammatory Bowel Disease
Management of Inflammatory Bowel Disease
 
Pathophysiology of obstructive jaundice
Pathophysiology of obstructive jaundicePathophysiology of obstructive jaundice
Pathophysiology of obstructive jaundice
 
an Approach to Dyspepsia
an Approach to Dyspepsiaan Approach to Dyspepsia
an Approach to Dyspepsia
 
IBS
IBSIBS
IBS
 
Gastritis
GastritisGastritis
Gastritis
 
Inflammatory bowel disease
Inflammatory bowel  diseaseInflammatory bowel  disease
Inflammatory bowel disease
 
Pathology of the Esophagus
Pathology of the EsophagusPathology of the Esophagus
Pathology of the Esophagus
 
GERD / GASTRO ESOPHAGEAL REFLUX
GERD / GASTRO ESOPHAGEAL REFLUX GERD / GASTRO ESOPHAGEAL REFLUX
GERD / GASTRO ESOPHAGEAL REFLUX
 
Gastric Carcinoma
Gastric CarcinomaGastric Carcinoma
Gastric Carcinoma
 
inflammatory bowel disease
inflammatory bowel diseaseinflammatory bowel disease
inflammatory bowel disease
 
Liver & its diseases
Liver & its diseasesLiver & its diseases
Liver & its diseases
 

Similar to Gastric Dyspepsia

GIT pharmacology
GIT pharmacologyGIT pharmacology
GIT pharmacologyAhmad Ali
 
GASTRO ESOPHAGEAL REFLUX DISEASE
GASTRO ESOPHAGEAL REFLUX DISEASEGASTRO ESOPHAGEAL REFLUX DISEASE
GASTRO ESOPHAGEAL REFLUX DISEASEMuthu Rajathi
 
Approach to nausea and vomting- general medicine- gastroenterology
Approach to nausea and vomting- general medicine- gastroenterologyApproach to nausea and vomting- general medicine- gastroenterology
Approach to nausea and vomting- general medicine- gastroenterologyhrtvkjaiswal
 
introduction of lower GI disorders
introduction of lower GI disordersintroduction of lower GI disorders
introduction of lower GI disordersneha maurya
 
Digestive system and its disease
Digestive system and its diseaseDigestive system and its disease
Digestive system and its diseasePooja Goswami
 
Gastro-esophageal Reflux Disease
Gastro-esophageal Reflux DiseaseGastro-esophageal Reflux Disease
Gastro-esophageal Reflux Diseaseasia said
 
Chapter 6.Gastrointestinal Disorder.pptx
Chapter 6.Gastrointestinal Disorder.pptxChapter 6.Gastrointestinal Disorder.pptx
Chapter 6.Gastrointestinal Disorder.pptx7ReeshabhBele
 
Document from Sai.pptx
Document from Sai.pptxDocument from Sai.pptx
Document from Sai.pptxAnkit Anand
 
Elimination 090828094056-phpapp01 (1)
Elimination 090828094056-phpapp01 (1)Elimination 090828094056-phpapp01 (1)
Elimination 090828094056-phpapp01 (1)kingfaisalafridi
 
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...Vinitkumar MJ
 
gastrointestinal-system-disorders.pptx
gastrointestinal-system-disorders.pptxgastrointestinal-system-disorders.pptx
gastrointestinal-system-disorders.pptxMohammedAbdela7
 
Gastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxGastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxSudipta Roy
 
ZOLLINGER-ELLISON SYNDROME
ZOLLINGER-ELLISON SYNDROMEZOLLINGER-ELLISON SYNDROME
ZOLLINGER-ELLISON SYNDROMEMa Wady
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer diseaseHIRENGEHLOTH
 
Chronic enteritis and colitis Mohit
Chronic enteritis and colitis MohitChronic enteritis and colitis Mohit
Chronic enteritis and colitis Mohitmohit rulaniya
 

Similar to Gastric Dyspepsia (20)

GIT pharmacology
GIT pharmacologyGIT pharmacology
GIT pharmacology
 
GASTRO ESOPHAGEAL REFLUX DISEASE
GASTRO ESOPHAGEAL REFLUX DISEASEGASTRO ESOPHAGEAL REFLUX DISEASE
GASTRO ESOPHAGEAL REFLUX DISEASE
 
Approach to nausea and vomting- general medicine- gastroenterology
Approach to nausea and vomting- general medicine- gastroenterologyApproach to nausea and vomting- general medicine- gastroenterology
Approach to nausea and vomting- general medicine- gastroenterology
 
introduction of lower GI disorders
introduction of lower GI disordersintroduction of lower GI disorders
introduction of lower GI disorders
 
Digestive system and its disease
Digestive system and its diseaseDigestive system and its disease
Digestive system and its disease
 
Gastro-esophageal Reflux Disease
Gastro-esophageal Reflux DiseaseGastro-esophageal Reflux Disease
Gastro-esophageal Reflux Disease
 
Chronic diarrhea
Chronic diarrhea Chronic diarrhea
Chronic diarrhea
 
Chapter 6.Gastrointestinal Disorder.pptx
Chapter 6.Gastrointestinal Disorder.pptxChapter 6.Gastrointestinal Disorder.pptx
Chapter 6.Gastrointestinal Disorder.pptx
 
Document from Sai.pptx
Document from Sai.pptxDocument from Sai.pptx
Document from Sai.pptx
 
Elimination 090828094056-phpapp01 (1)
Elimination 090828094056-phpapp01 (1)Elimination 090828094056-phpapp01 (1)
Elimination 090828094056-phpapp01 (1)
 
Gi disorders
Gi disordersGi disorders
Gi disorders
 
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 
gastrointestinal-system-disorders.pptx
gastrointestinal-system-disorders.pptxgastrointestinal-system-disorders.pptx
gastrointestinal-system-disorders.pptx
 
Gastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxGastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptx
 
chronic colitis
chronic colitischronic colitis
chronic colitis
 
ZOLLINGER-ELLISON SYNDROME
ZOLLINGER-ELLISON SYNDROMEZOLLINGER-ELLISON SYNDROME
ZOLLINGER-ELLISON SYNDROME
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
Chronic enteritis and colitis Mohit
Chronic enteritis and colitis MohitChronic enteritis and colitis Mohit
Chronic enteritis and colitis Mohit
 
PUD
PUDPUD
PUD
 

More from Alok Kumar

Alok Kumar (Grp 09) Scarlet Fever.pptx
Alok Kumar (Grp 09) Scarlet Fever.pptxAlok Kumar (Grp 09) Scarlet Fever.pptx
Alok Kumar (Grp 09) Scarlet Fever.pptxAlok Kumar
 
Alok Kumar (Grp 09) Rubella.pptx
Alok Kumar (Grp 09) Rubella.pptxAlok Kumar (Grp 09) Rubella.pptx
Alok Kumar (Grp 09) Rubella.pptxAlok Kumar
 
Alok Kumar (Grp 09) Measures Of Association.pptx
Alok Kumar (Grp 09) Measures Of Association.pptxAlok Kumar (Grp 09) Measures Of Association.pptx
Alok Kumar (Grp 09) Measures Of Association.pptxAlok Kumar
 
Alok Kumar (Grp 09) Measles.pptx
Alok Kumar (Grp 09) Measles.pptxAlok Kumar (Grp 09) Measles.pptx
Alok Kumar (Grp 09) Measles.pptxAlok Kumar
 
Alok Kumar (Grp 09) Fascioliasis.pptx
Alok Kumar (Grp 09) Fascioliasis.pptxAlok Kumar (Grp 09) Fascioliasis.pptx
Alok Kumar (Grp 09) Fascioliasis.pptxAlok Kumar
 
Alok Kumar (Grp 09) Amoebiasis.pptx
Alok Kumar (Grp 09) Amoebiasis.pptxAlok Kumar (Grp 09) Amoebiasis.pptx
Alok Kumar (Grp 09) Amoebiasis.pptxAlok Kumar
 
Alok Kumar (Grp 09) Sem 09 Types Of Heart Block.pptx
Alok Kumar (Grp 09) Sem 09 Types Of Heart Block.pptxAlok Kumar (Grp 09) Sem 09 Types Of Heart Block.pptx
Alok Kumar (Grp 09) Sem 09 Types Of Heart Block.pptxAlok Kumar
 
Ionizing Radiation & Health
Ionizing Radiation & HealthIonizing Radiation & Health
Ionizing Radiation & HealthAlok Kumar
 
Cognitive Examination
Cognitive ExaminationCognitive Examination
Cognitive ExaminationAlok Kumar
 
Frontal Lobe Lesion
Frontal Lobe LesionFrontal Lobe Lesion
Frontal Lobe LesionAlok Kumar
 
Integumentery System
Integumentery SystemIntegumentery System
Integumentery SystemAlok Kumar
 
Skeletal System
Skeletal SystemSkeletal System
Skeletal SystemAlok Kumar
 
Histology Of Liver
Histology Of LiverHistology Of Liver
Histology Of LiverAlok Kumar
 
Joint Disorder MCQs
Joint  Disorder MCQsJoint  Disorder MCQs
Joint Disorder MCQsAlok Kumar
 
Systemic Connective Tissue Inflammatory Syndrome Lecture 4
Systemic Connective Tissue Inflammatory Syndrome Lecture 4Systemic Connective Tissue Inflammatory Syndrome Lecture 4
Systemic Connective Tissue Inflammatory Syndrome Lecture 4Alok Kumar
 
Inflammatory Periarticular Lesions Lecture 3
Inflammatory Periarticular Lesions Lecture 3Inflammatory Periarticular Lesions Lecture 3
Inflammatory Periarticular Lesions Lecture 3Alok Kumar
 
Degenerative Joint Disorder Syndrome Lecture 2
Degenerative Joint Disorder Syndrome Lecture 2Degenerative Joint Disorder Syndrome Lecture 2
Degenerative Joint Disorder Syndrome Lecture 2Alok Kumar
 
Joint Disorders Lecture 1
Joint  Disorders Lecture 1Joint  Disorders Lecture 1
Joint Disorders Lecture 1Alok Kumar
 
Sensitivity (Neurology 4)
Sensitivity (Neurology 4)Sensitivity (Neurology 4)
Sensitivity (Neurology 4)Alok Kumar
 
Motor System (Neurology 2)
Motor System (Neurology 2)Motor System (Neurology 2)
Motor System (Neurology 2)Alok Kumar
 

More from Alok Kumar (20)

Alok Kumar (Grp 09) Scarlet Fever.pptx
Alok Kumar (Grp 09) Scarlet Fever.pptxAlok Kumar (Grp 09) Scarlet Fever.pptx
Alok Kumar (Grp 09) Scarlet Fever.pptx
 
Alok Kumar (Grp 09) Rubella.pptx
Alok Kumar (Grp 09) Rubella.pptxAlok Kumar (Grp 09) Rubella.pptx
Alok Kumar (Grp 09) Rubella.pptx
 
Alok Kumar (Grp 09) Measures Of Association.pptx
Alok Kumar (Grp 09) Measures Of Association.pptxAlok Kumar (Grp 09) Measures Of Association.pptx
Alok Kumar (Grp 09) Measures Of Association.pptx
 
Alok Kumar (Grp 09) Measles.pptx
Alok Kumar (Grp 09) Measles.pptxAlok Kumar (Grp 09) Measles.pptx
Alok Kumar (Grp 09) Measles.pptx
 
Alok Kumar (Grp 09) Fascioliasis.pptx
Alok Kumar (Grp 09) Fascioliasis.pptxAlok Kumar (Grp 09) Fascioliasis.pptx
Alok Kumar (Grp 09) Fascioliasis.pptx
 
Alok Kumar (Grp 09) Amoebiasis.pptx
Alok Kumar (Grp 09) Amoebiasis.pptxAlok Kumar (Grp 09) Amoebiasis.pptx
Alok Kumar (Grp 09) Amoebiasis.pptx
 
Alok Kumar (Grp 09) Sem 09 Types Of Heart Block.pptx
Alok Kumar (Grp 09) Sem 09 Types Of Heart Block.pptxAlok Kumar (Grp 09) Sem 09 Types Of Heart Block.pptx
Alok Kumar (Grp 09) Sem 09 Types Of Heart Block.pptx
 
Ionizing Radiation & Health
Ionizing Radiation & HealthIonizing Radiation & Health
Ionizing Radiation & Health
 
Cognitive Examination
Cognitive ExaminationCognitive Examination
Cognitive Examination
 
Frontal Lobe Lesion
Frontal Lobe LesionFrontal Lobe Lesion
Frontal Lobe Lesion
 
Integumentery System
Integumentery SystemIntegumentery System
Integumentery System
 
Skeletal System
Skeletal SystemSkeletal System
Skeletal System
 
Histology Of Liver
Histology Of LiverHistology Of Liver
Histology Of Liver
 
Joint Disorder MCQs
Joint  Disorder MCQsJoint  Disorder MCQs
Joint Disorder MCQs
 
Systemic Connective Tissue Inflammatory Syndrome Lecture 4
Systemic Connective Tissue Inflammatory Syndrome Lecture 4Systemic Connective Tissue Inflammatory Syndrome Lecture 4
Systemic Connective Tissue Inflammatory Syndrome Lecture 4
 
Inflammatory Periarticular Lesions Lecture 3
Inflammatory Periarticular Lesions Lecture 3Inflammatory Periarticular Lesions Lecture 3
Inflammatory Periarticular Lesions Lecture 3
 
Degenerative Joint Disorder Syndrome Lecture 2
Degenerative Joint Disorder Syndrome Lecture 2Degenerative Joint Disorder Syndrome Lecture 2
Degenerative Joint Disorder Syndrome Lecture 2
 
Joint Disorders Lecture 1
Joint  Disorders Lecture 1Joint  Disorders Lecture 1
Joint Disorders Lecture 1
 
Sensitivity (Neurology 4)
Sensitivity (Neurology 4)Sensitivity (Neurology 4)
Sensitivity (Neurology 4)
 
Motor System (Neurology 2)
Motor System (Neurology 2)Motor System (Neurology 2)
Motor System (Neurology 2)
 

Recently uploaded

UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfUGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfNirmal Dwivedi
 
What is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptxWhat is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptxCeline George
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptxJoelynRubio1
 
Ernest Hemingway's For Whom the Bell Tolls
Ernest Hemingway's For Whom the Bell TollsErnest Hemingway's For Whom the Bell Tolls
Ernest Hemingway's For Whom the Bell TollsPallavi Parmar
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111GangaMaiya1
 
How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17Celine George
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxakanksha16arora
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptNishitharanjan Rout
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsSandeep D Chaudhary
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...EADTU
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...Gary Wood
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17Celine George
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxEsquimalt MFRC
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of PlayPooky Knightsmith
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Celine George
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptxMichaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptxRugvedSathawane
 

Recently uploaded (20)

UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfUGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
 
What is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptxWhat is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptx
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
Ernest Hemingway's For Whom the Bell Tolls
Ernest Hemingway's For Whom the Bell TollsErnest Hemingway's For Whom the Bell Tolls
Ernest Hemingway's For Whom the Bell Tolls
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111
 
How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of Play
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptxMichaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
 

Gastric Dyspepsia

  • 1.
  • 3. Dyspepsia - digestive disorders of different origin s. There are gastric and intestinal dyspepsia. T he term "gastric dyspepsia" combines symptom s such as heartburn, belching, regurgitation, na usea, vomiting, hiccups. They are observed not only in various diseases of the stomach, but in diseases of other organs and systems (central nervous system, endocrine system, liver, biliary tract, kidneys, and others.).
  • 4. The organic reasons of dyspepsia: • Gastritis; • Stomach ulcer; • Reflux- esophagitis; • Stomach cancer; • Cholelithiasis; • Chronic pancreatitis.
  • 5. Gastritis - inflammation of the mucous membrane of the stomach wall.
  • 6. common causes of gastritis. The most common cause of gastritis is the bacterium Helicobacter pylori, however, co ntribute to the development of gastritis ma y be poor nutrition, constant stress, smoki ng, alcoholism, medications, error in nutriti on.
  • 7. types of gastritis. etiological • 1. Helicobacter pylori (associated with Helicoba cter pylori) • 2. Autoimmune • 3. Reactive (due to duodenal reflux, bile reflux i nto the stomach or taking drugs) • 4. Special forms of gastritis (granulomatous, inc luding Crohn's disease, sarcoidosis, tuberculosi s, lymphocytic, eosinophilic)
  • 8. types of gastritis. on the course of the disease. • acute gastritis • chronic gastritis topography • 1. Gastritis antrum • 2. The body of the stomach Gastritis • 3. pangastritis
  • 9. types of gastritis. Endoscopic gastritis categories: • 1. erythematous-exudative (surface), gastritis • 2. atrophic gastritis • 3. hemorrhagic gastritis • 4. hyperplastic gastritis
  • 10. Chronic H. pylori gastritis In the early stages of the disease developing atr ophic antral gastritis without secretory failure. Ulcer-like symptoms: • Pain in the epigastric 1-2 hours after a meal • Hunger pain (fasting) • Heartburn, acid regurgitation • A healthy appetite • The tendency to constipation
  • 11. Objective clinical symptoms: • Language clean or slightly coated from root • Local tenderness in the area piloroduodenalnoy • Normal border stomach
  • 12. In the late stages of the disease devel ops diffuse gastritis with atrophy of th e gastric mucosa and the secretory de ficiency.
  • 13. Clinical symptoms: • Poor appetite, nausea • metallic taste in the mouth, dry mouth • Belching air, food, sometimes rotten • The feeling of heaviness in the epigastric • Dull epigastric pain after eating • Rumbling and flatulence • Frequent loose stools
  • 14. Objective symptoms • Weight loss • Language thickly coated • Perleches in the corners of the mouth • Moderate diffuse pain in the epigastric region • Omission of the lower boundary of the stomach • Rumbling palpation of the large intestine due to t he pronounced flatulence
  • 15. Perleches in the corners of the mouth
  • 16. survey X - ray examination of the stomach: • Early stage (non-atrophic gastritis) - rough terrai n mucosa in the antrum, pyloric spasm, segmen ted peristalsis, disorderly evacuation of a contra st agent. • Late stage (pangastritis with atrophy) - relief of g astric mucosa smoothed, hypotension, sluggish perstaltika, fast evacuation of contrast material.
  • 17. X - ray examination of the stomach
  • 18. Gastroscopy • Early stage (non-atrophic gastritis) - blotchy red ness and swelling of the mucous membrane of t he antrum, frequent submucosal hemorrhage, e rosion, hyperplasia folds, exudation, antral spas ms, stasis. • Late stage (pangastritis with atrophy) - paleness , thinning, flattening of the mucous membrane i n the stomach and the antrum, blotchy flushing, candling vascular hypotension, increased vulne rability of the mucous, reflux of duodenal conten ts.
  • 19.
  • 22. Mucosal erythema and edema co nsistent with acute gastritis.
  • 23. Acute gastritis with superficial ero sions.
  • 24. Histopathological examination (biopsy taken at least 2 pieces of the antrum and the body (front and rear), a lways with a muscular plate): • Early stage (non-atrophic gastritis) - pronounced active antral gastritis (infiltration own skin epithelial lymphocy tes, plasmocytes, neutrophils), foci of intestinal metapl asia, a lot of helicobacter surface and mucous pits. • Late stage (pangastritis with atrophy) - glandular epithe lium atrophy, intestinal metaplasia, a small amount of helicobacter in gastric mucosa and antrum, the minim al activity of inflammation.
  • 25. Diagnosis of Helicobacter pylory: Histological method for determining Helicobacter pylori is the gold standard of diagnosis: • Thin slices of biopsy specimens stained by the method of Giemsa-Romanovsky, Helicobacter l ocated in the mucus, have a spiral shape. There are three degrees of contamination Helioba cter pylory: • Low () - 20 microbial cells in the s.v. • Average (++) - up to 50 microbial cells in the s.v . • High (+++) - more than 50 microbial cells in the s.v.
  • 26. Chronic autoimmune gastritis. Chronic autoimmune gastritis is chara cterized by lesions of the gastric fund us, atrophy of the gastric mucosa and the secretory deficiency.
  • 27. Subjective symptoms • feeling of heaviness and fullness after eating • Belching air, rotten, food sedennoy • metallic taste in the mouth • Poor appetite • Rumbling transfusions and stomach, unstable st ool • severe weakness, dizziness, sweating (function al dumping syndrome)
  • 28. Objective symptoms • Weight Loss • pale skin (anemia), hair loss, brittle nails • Dry skin, hyperpigmentation (gipokortitsizm) • Signs gipopolivitaminoza (dry skin, blurred vision, blee ding of gums and loosening, Zayed corners of mouth, dermatitis, diarrhea) • coated tongue • Sore epigastrii • Morbidity and rumbling in the umbilical and the ileocec al region • Omission of the greater curvature of the stomach
  • 29. X-ray examination of the stomach Improvement in the folds of the stomach lining
  • 30. Gastroscopy • The folds of the gastric mucosa are reduced in v olume, in advanced cases of atrophy, they can be absent • stomach lining thinned, atrophic, pale, clearly vi sible vascular pattern, an excessive amount of mucus • hiatus gatekeeper, throw the stomach contents of 12 duodenal ulcer, gastric motility sluggish • antrum is not changed
  • 31. Histopathological examination • atrophy of the mucous membrane of the fundus of the stomach with the replacement of speciali zed glands psevdopiloric glands and intestinal e pithelium.
  • 32. Immunological blood tests • The presence of autoantibodies to parietal cells and gastromukoproteinu.
  • 33. Special forms of gastritis. Hypertrophic gastritis (Menetries disease). Subjective symptoms: • Intense epigastric pain occurring after meals, he artburn, regurgitation, air and food • Frequent vomiting with blood • Anorexia • Weight loss, swelling of the feet and hands • Diarrhea • Hypoproteinemia
  • 34. Special forms of gastritis. Hypertrophic gastritis (Menetries disease). Gastroscopy: • Hypertrophy of the mucous membrane in the for m of giant folds, covered with lots of sticky muc us. Histopathological examination: • The sharp thickening of the gastric mucosa, ext ension and expansion of the gastric pits
  • 37. treatment 1. Sparing diet. Vegetables boiled, steamed zucc hini, potatoes, carrots, cabbage, beans, beets, dairy products, fruit and berry juices, sauces, spices, snacks, tea, coffee and black with milk , broth hips, black currant). Excluded are indig estible, long linger in the stomach and dishes. Fractional meals 4-5 times a day.
  • 38. treatment Anti-inflammatory therapy • Sucralfate (Venter) Tablets (1 g) 1 tab four time s daily (for 1 hour before meals and at bedtime) or 2 g in the morning and evening. The course of treatment 2-4 weeks or • De-nol (colloidal bismuth subcitrate) Tablets (12 0 mg) 1 tablet three times a day 30 minutes bef ore meals and at bedtime. The course of treatm ent 4 - 8 weeks. For 30 minutes before and afte r taking the drug should not take antacids, milk, beverages, solid food.
  • 39. treatment Cementing and enveloping substance • Allonton (drug inula) Tablets (0.1) 1 tab. 2-4 tim es for 30 min. before meals or • Kaleflon (extract from marigold flowers) Tablets (0.1) Table 1-2. 3 times per day after meals
  • 40. treatment Stimulators of gastric secretion • Trental (metabolic drug in combination with the i mprovement of microcirculation) 100 mg 1-2 tab . 3 times for 30 min. before meals for 1-2 month s. or • Pentagastrin (synthetic analog of histamine) Am poule 0.025% -1.0 s/c before meal 1-2 times a day for two weeks
  • 41. treatment replacement therapy drugs. • Gastric juice natural vials of 1-2 tablespoons int o ½ cup of water through a straw while eating or • Citric acid powder on the tip of a knife into ¼ cu p of water with meals or • Atsidin-pepsin tablets (0.5) Table 1. dissolved in ½ cup of water with meals
  • 42. treatment prokinetics. • Metoclopramide (raglan, Reglan) Tablets (0.01) Ampules (1 ml-0.005) 10-20 mg 3-4 times a day for 15-30 minutes before meal, maximum daily dose of 60 mg or • Motilium (domperidone) Tablets 0.01 mg 10-20 3-4 times a day for 15-30 minutes before meals, daily dose - 60 mg
  • 43. treatment • Pancreatin Tablets 0.5-1.0 The enzyme prepara tion from the pancreas of beef cattle. Table 1-2. before meals 3-4 times or • Mezim forte preparation containing pancreatic e nzymes 1-2 tab. 3 times daily before or during meals
  • 44. treatment Antibiotics to treat Helicobacter pylori
  • 46. Peptic ulcer - an independent (primary) chronic relapsing disease gastroduodenal region with th e formation of ulcers of the stomach and duode num.
  • 47. Peptic ulcer Peptic ulcer duodenal bulb (PUD) occurs 4 time s more often than gastric ulcer (GU). Peptic ulcer duodenal bulb - is more common in t he age range 25-75 years (rarely less than 15 y ears). GU - occurs more often aged 55-65 (rarely young er than 40 years).
  • 48. The criteria for early diagnosis. • epigastric pain - in the center or left of the midlin e at a stomach ulcer, epigastric right of the midli ne - duodenal ulcer and prepiloric area with ga stric cardia of the stomach - in the sternum. • Early pain (30 minutes - 1 hour after a meal) - at the top of the stomach ulcer, recent pain (1.5 - 2 hours after a meal), night and hungry (after 6- 7 hours after eating) - ulcer antral department a nd duodenal ulcer.
  • 49. The criteria for early diagnosis. • Dumb nature of pain can be aching, boring • The frequency of pain • Relief of pain - after antacids, milk, food, of ten after vomiting • Seasonality pain - spring, autumn, charact erized more for duodenal ulcer • Heartburn
  • 50. The criteria for early diagnosis. • Belching, often occurs in the localization fi eld mesogastric • Nausea – characteristic for mediogastral ul cers, but not characteristic of ulcer 12 duo denal ulcer • Vomiting - at an altitude of pain • Appetite - kept, good
  • 51.
  • 52. The criteria for early diagnosis. objective: • Asthenia • The tendency to bradycardia • Tendency to hypertension • Moderate or severe pain in the epigastric in acut e: gastric ulcer - midline or left, ulcer 12 duoden al ulcer over the right • percussion tenderness over the area of the ulcer - a symptom of Mendel • Local protective tension anterior abdominal wall
  • 53. The criteria for early diagnosis. Laboratory research: • CBC - a slight increase in red blood cells and h emoglobin • Fecal occult blood test (reaction Gregersen) - p ositive for bleeding from the ulcer
  • 54. The criteria for early diagnosis. Endoscopy: • Ulcers round, polygonal or slit form • Borders ulcers crisp, edge bloodshot, swollen • Undermining the ulcer edge (facing the cardiac department), the distal end flat • The bottom of the ulcer is covered with fibrin
  • 56.
  • 57.
  • 58. Gastric ulcer with punched-out ulcer base with whitish fibrinoid exudates.
  • 59. Gastric ulcer (lesser curvature) with punched -out ulcer base with whitish exudate.
  • 60. The criteria for early diagnosis. X-rays: Direct indication of the "niche" Indirect signs: • Delay barium mass at the site of the ulcer (contrast stai n resistant) • Delayed or accelerated passage of barium sulfate of st omach • Duodenalnogastralny reflux • Convergence folds at locations ulcers • Lack of cardia, gastroesophageal reflux • Local stomach cramps or 12 duodenal ulcer • Symptom De Quervain - circular retraction of the muscl es on the opposite side of the stomach ulcer - deforma tion of the stomach and duodenum
  • 62. Determination Helicobacter pylori • urease breath test - identifying exhaled C13 isotopes w hich are formed in the stomach during digestion drunk labeled urea by the action of urease HP • histological methods - detection of HP in biopsies stain ed by the method of Giemsa • urease biopsy test - determination of urease activity of HP in biopsies • The bacteriological test - the growth of HP biopsy • Immunological methods - determination of antibodies in the blood to HP, HP detection of antigen in stool
  • 63. Required laboratory tests • Complete blood count - once (In the event of rep eated study of 1 every 10 days) • Blood type • Fecal occult blood test
  • 64. The severity of the ulcer Mild - is characterized by the following features: • Exacerbations 1 time in 1-3 years • Pain syndrome moderate pain stoped for 4-7 da ys • shallow ulcer • The remission disabled preserved
  • 65. The severity of the ulcer moderate severity: • Relapse 2 times a year • Pain syndrome pronounced pain stoped in the h ospital for 10-14 days • Characterized dyspepsia • Ulcers deep, often bleeds, accompanied by phe nomena perigastritis, periduodenitis
  • 66. The severity of the ulcer Severe: • Relapse 2-3 times a year and more • Pain and pronounced cropped in the hospital for 2 weeks or more • Sharply expressed dyspeptic symptoms and wei ght loss • The ulcer is often complicated by bleeding, deve lopment of pyloric stenosis, perigastritis, peridu odenitis
  • 67. Complications of peptic ulcer disease. • Peptic ulcer bleeding is observed in 15-25% of patie nts with peptic ulcer disease, often with stomach ulcer s localization • Ulcer perforation occurs in 5% of patients with peptic ulcer disease, more common in men. • Penetration - penetration of gastric ulcer or duodenal ulcer in the surrounding tissues: the pancreas, a small gland, gall bladder, and others. • Perivistserit - adhesive process that evolves with ulce rs between the stomach or duodenum and adjacent or gans (pancreas, liver, gall bladder). duodenum.
  • 69. Complications of peptic ulcer disease. • Pyloric stenosis usually formulated after ulc er healing located in the pyloric channel or the i nitial part of the duodenum, is found in 5% of pa tients. • The risk of malignancy (adenocarcinoma devel opment) benign ulcers when infected with HP 9 times more likely than uninfected patients.
  • 70. treatment 1. Medical treatment - mental and physical rest, n ot strict bed rest for 7-10 days, then free. 2. Diet - table 1 a, 1 b for 2-3 days, then the table 1. The food is cooked, but not shabby, eat 5-6 ti mes a day are not recommended sharp, pickled , smoked food. The optimum amount of protein i n the diet of 120-125 g / day. 3. Giving up smoking. 4. Pharmacotherapy.
  • 71. treatment H. pylori therapy • First-line therapy (triple therapy) for 7 days Omeprazole 20 mg 2 times a day, or Lansoprazole 30 mg 2 times a day, or Pantoprozol 40 mg 2 times a day + Clarithromycin 500 mg 2 times a day + Amoxicillin 1000 mg 2 times a day or Clarithromycin 500 mg 2 times a day + Metronidazole 500 mg 2 times a day
  • 72. treatment H. pylori therapy • First-line therapy (triple therapy) for 7 days Omeprazole 20 mg 2 times a day, Clarithromycin 500 mg 2 times a day Amoxicillin 1000 mg 2 times a day
  • 73. treatment H. pylori therapy Second-line therapy (quadruple) for 7 days Omeprazole 20 mg 2 times a day, or Lansoprazole 30 mg 2 times a day, or Pantoprozol 40 mg 2 times a day + Bismuth subsalicylate 120 mg four times a day + Metronidazole 500 mg three times a day + Tetracycline 500 mg four times a day
  • 74. treatment H. pylori therapy Second-line therapy (quadruple) for 7 days Omeprazole 20 mg 2 times a day, Bismuth subsalicylate 120 mg four times a day Metronidazole 500 mg three times a day Tetracycline 500 mg four times a day
  • 76. stomach cancer Stomach cancer - a malignant tumor growing fro m the epithelial cells of the mucosa (inner) mem brane of the stomach. Swelling can occur in diff erent parts of the stomach: at the top, where it c onnects with the esophagus, in the main part (b ody) of the stomach or in the bottom where the stomach is connected to the intestines.
  • 77. stomach cancer Risk factors for gastric cancer • Genetic predisposition - if someone in the family d iagnosed with stomach cancer, then all the other r elatives (blood) relatives likely to develop increase d by 20%; • eating habits - overreliance smoked, spicy, salty, f ried (overcooked) and canned food, long stored fo ods containing nitrates, significantly increases the risk of stomach cancer; • long-existing diseases of the stomach: gastritis (w ith low acidity), ulcers and polyps of the stomach; • gastric surgery increases the risk of gastric cance r development is 2.5 times;
  • 78. stomach cancer Risk factors for gastric cancer • the presence of the stomach bacterium Helicobact er pylori: In 1994 the World Health Organization (W HO) has recognized the link between Helicobacter Pylori and stomach cancer and the bacteria broug ht it into the category of carcinogens of the first cl ass; • Work with asbestos and nickel; • deficiency of vitamin B12, and C; • primary and secondary (e.g., AIDS), immunodefici ency states; • 20 times more common in gastric cancer patients with pernicious (malignant) anemia; • Some viruses, such as Epstein-Barr virus; • alcoholism and smoking.
  • 79. stomach cancer clinical picture • decreased appetite; • changes in eating habits, for example, they feel an aversion to meat, fish and etc .; • rise in temperature (usually 37-38 ° C); • anemia (decreased hemoglobin).
  • 80. stomach cancer clinical picture With the growth of stomach cancer, new symptoms: • a feeling of heaviness in the stomach after eating, nau sea and vomiting, fast saturation; • violation stool (diarrhea, constipation); • pain in the upper abdomen, girdle pain, smack in the b ack (in the propagation of the tumor in the pancreas); • increasing the size of the stomach, fluid accumulation i n the abdomen (ascites); • weight loss; • the destruction of tumor blood vessels may develop ga strointestinal bleeding.
  • 81. Physical examination Objective methods of inspection (survey, pa lpation, percussion) allow revealing a stom ach cancer only at late stages of disease.
  • 82. TOOL METHODS of INVESTIGATION • gastroscopy with biopsies. • computed tomography • US • x-ray study.
  • 83. Gastric cancer. Note the irregul ar heaped up overhanging margi ns.
  • 84. Gastric cancer with ulcerated ma ss.
  • 85. Thank you for the attention.